Cancer remains a significant global health challenge, with chronic inflammation often driving in tumor development and progression. Consequently, the search for novel anti-inflammatory agents to complement conventional cancer therapies is crucial. Triiptolide, a synthetic derivative of the natural product triptolide, has emerged as a promising cand

Barzolvolimab: A New Possibility for Inflammatory Ailments? Barzolvolimab, a recently identified biological compound, is creating significant interest within the scientific field. This innovative antibody functions as a potent blocker of IL- 17F read more cytokine, a vital mediator in the development of various inflammatory conditions, including I